Arcelis AGS-004 dendritic cell-based immunotherapy for HIV infection

Immunotherapy
Jean-Pierre Routy, C A Nicolette

Abstract

Antiretroviral therapy represents a major breakthrough for the management of HIV-infected patients; however, it is not without side effects and is a life-long commitment. Thus, the development of novel strategies to enhance immune response and control viral replication are needed in order to limit exposure to antiretroviral therapy. To date, immunotherapies consisting of monocyte-derived dendritic cells expressing HIV antigens have elicited only limited immunogenicity and/or viral control. Thus, taking into consideration the variability of HIV, an investigational immunotherapeutic product (AGS-004, Argos Therapeutics Inc., NC, USA) that consists of autologous dendritic cells co-electroporated with in vitro transcribed RNA encoding four of the patient's own HIV antigens was developed. Based on the encouraging immunogenicity and tolerance observed in a Phase I study, a Phase II study has been initiated with good tolerance and partial viral control. A second Phase II placebo-controlled study is about to initiate.

References

Jan 7, 1998·Immunological Reviews·O J CohenA S Fauci
Apr 1, 1998·Nature·J Banchereau, R M Steinman
Feb 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·B PulendranC R Maliszewski
Aug 18, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·M AltfeldUNKNOWN HIV Study Collaboration
Aug 9, 2002·The New England Journal of Medicine·Susan J LittleDouglas D Richman
Oct 29, 2002·The Journal of Infectious Diseases·Mary A MarovichSarah Schlesinger-Frankel
Dec 24, 2002·Nature Medicine·Wei LuJean-Marie Andrieu
Apr 19, 2003·Cancer Immunology, Immunotherapy : CII·Michael G E O'RourkeChristopher W Schmidt
Feb 27, 2004·The Journal of Antimicrobial Chemotherapy·S Kinloch-de Loes
Jul 13, 2004·Science·Brigitte AutranPatrice Debre
Nov 30, 2004·Nature Medicine·Wei LuJean-Marie Andrieu
Dec 22, 2004·International Immunology·Karuppiah MuthumaniDavid B Weiner
Feb 3, 2005·Nature Immunology·Hans Christian ProbstMaries van den Broek
Aug 2, 2005·Nature Reviews. Immunology·Gwendalyn J RandolphMelody A Swartz
Aug 10, 2006·The Journal of Infectious Diseases·Jeffrey M JacobsonUNKNOWN National Institute of Allergy and Infectious Diseases-AIDS Clinical Trials Group 5068 Protocol Team
Aug 19, 2006·Nature Medicine·Lydie TrautmannRafick-Pierre Sekaly
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Maria Giovanna QuarantaMarina Viora
Nov 23, 2006·Nature Medicine·Jason M BrenchleyDaniel C Douek
Dec 16, 2006·Nature Reviews. Immunology·Ken Shortman, Shalin H Naik
Feb 20, 2007·Proceedings of the National Academy of Sciences of the United States of America·Xunrong LuoManikkam Suthanthiran
Apr 13, 2007·Proceedings of the National Academy of Sciences of the United States of America·Asier Sáez-CiriónUNKNOWN Agence Nationale de Recherches sur le Sida EP36 HIV Controllers Study Group
May 16, 2007·AIDS·Amanda MocroftJens D Lundgren
Jun 15, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Mohamed-Rachid BoulasselJean-Pierre Routy
Sep 15, 2007·Nature Reviews. Immunology·Paul J TackenCarl G Figdor
Sep 28, 2007·Nature·Ralph M Steinman, Jacques Banchereau
Feb 16, 2008·The Journal of Infectious Diseases·Florencia PereyraBruce D Walker
Jun 7, 2008·Nature Medicine·Victor AppayDavid A Price

❮ Previous
Next ❯

Citations

Mar 13, 2013·Current Opinion in HIV and AIDS·Giuseppe Pantaleo, Yves Lévy
Jun 19, 2013·Immunological Reviews·Elizabeth Miller, Nina Bhardwaj
Jan 12, 2016·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Jeffrey M JacobsonCharles Nicolette
Jun 27, 2014·Vaccine·Authors Kevin FisherRichard Jefferys
Jan 28, 2015·The Open AIDS Journal·Vikram MehrajJean-Pierre Routy
Nov 13, 2012·PloS One·Carmen Álvarez-FernándezSonsoles Sánchez-Palomino
Jan 8, 2020·Viruses·Jan KristoffRobbie B Mailliard
May 26, 2018·Indian Journal of Dermatology, Venereology and Leprology·Edith HannaMazen Kurban

❮ Previous
Next ❯

Methods Mentioned

BETA
leukapheresis
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.